Yazawa S - Search Results

1

Characterization of BRAF^Thr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling.

Watanabe H, Inoue Y, Karayama M, Yazawa S, Mochizuka Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Shinmura K, Inui N, Suda T. Watanabe H, et al. Among authors: yazawa s. JCO Precis Oncol. 2024 Apr;8:e2300538. doi: 10.1200/PO.23.00538. JCO Precis Oncol. 2024. PMID: 38662982

2

Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study.

Enomoto N, Yazawa S, Mochizuka Y, Fukada A, Tanaka Y, Naoi H, Aono Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Furuhashi K, Toyoshima M, Kono M, Imokawa S, Sano T, Akamatsu T, Koshimizu N, Yokomura K, Matsuda H, Kaida Y, Shirai M, Mori K, Masuda M, Fujisawa T, Inui N, Nakamura Y, Sugiura H, Sumikawa H, Kitani M, Tabata K, Ogawa N, Suda T. Enomoto N, et al. Among authors: yazawa s. Respir Med. 2024 Apr;224:107577. doi: 10.1016/j.rmed.2024.107577. Epub 2024 Feb 24. Respir Med. 2024. PMID: 38408707 Free article.

3

Long-Term Detection and Isolation of Severe Fever with Thrombocytopenia Syndrome (SFTS) Virus in Dog Urine.

Saga Y, Yoshida T, Yoshida R, Yazawa S, Shimada T, Inasaki N, Itamochi M, Yamazaki E, Oishi K, Tani H. Saga Y, et al. Among authors: yazawa s. Viruses. 2023 Nov 8;15(11):2228. doi: 10.3390/v15112228. Viruses. 2023. PMID: 38005905 Free PMC article.

4

Impact of COVID-19 and Closed Transmission of SARS-CoV-2 during the First Wave in Toyama Prefecture, Japan, March 30 to May 18, 2020.

Tamura K, Inasaki N, Itamochi M, Saga Y, Shimada T, Yazawa S, Sasajima H, Kawashiri C, Yamazaki E, Ichikawa T, Kaya H, Yamamoto Y, Morinaga Y, Yamashiro S, Nomura S, Takeda S, Ito H, Hirota K, Horie Y, Hirano N, Sekizuka T, Kuroda M, Tani H, Oishi K. Tamura K, et al. Among authors: yazawa s. Jpn J Infect Dis. 2024 Mar 21;77(2):75-82. doi: 10.7883/yoken.JJID.2023.210. Epub 2023 Oct 31. Jpn J Infect Dis. 2024. PMID: 37914293 Free article.

5

Virus evolution and reduced viral viability during treatment of persistent COVID-19 Omicron BA.5 infection in an immunocompromised host.

Kaya H, Tani H, Inasaki N, Yazawa S, Itamochi M, Higashi D, Tsuji N, Nakamura M, Oishi K. Kaya H, et al. Among authors: yazawa s. Int J Infect Dis. 2023 Nov;136:146-148. doi: 10.1016/j.ijid.2023.09.010. Epub 2023 Sep 16. Int J Infect Dis. 2023. PMID: 37722481 Free article.

6

Activation of SARS-CoV-2 by trypsin-like proteases in the clinical specimens of patients with COVID-19.

Yamazaki E, Yazawa S, Shimada T, Tamura K, Saga Y, Itamochi M, Inasaki N, Hasegawa S, Morinaga Y, Oishi K, Tani H. Yamazaki E, et al. Among authors: yazawa s. Sci Rep. 2023 Jul 19;13(1):11632. doi: 10.1038/s41598-023-38757-8. Sci Rep. 2023. PMID: 37468582 Free PMC article.

7

Evaluation of SARS-CoV-2 isolation in cell culture from nasal/nasopharyngeal swabs or saliva specimens of patients with COVID-19.

Yazawa S, Yamazaki E, Saga Y, Itamochi M, Inasaki N, Shimada T, Oishi K, Tani H. Yazawa S, et al. Sci Rep. 2023 Jun 1;13(1):8893. doi: 10.1038/s41598-023-35915-w. Sci Rep. 2023. PMID: 37264051 Free PMC article.

8

Neutralizing Antibody Levels and Epidemiological Characteristics of Patients with Breakthrough COVID-19 Infection in Toyama, Japan.

Tani H, Inasaki N, Yazawa S, Shimada T, Saga Y, Kaya H, Maruyama Y, Matano S, Itoh H, Kashii T, Yamazaki E, Itamochi M, Oishi K. Tani H, et al. Among authors: yazawa s. Jpn J Infect Dis. 2023 Sep 22;76(5):319-322. doi: 10.7883/yoken.JJID.2023.100. Epub 2023 May 31. Jpn J Infect Dis. 2023. PMID: 37258174 Free article.

9

Emergence of an erythroid cell-specific regulatory region in ABO intron 1 attributable to A- or B-antigen expression on erythrocytes in Hominoidea.

Sano R, Fukuda H, Kubo R, Oishi T, Miyabe-Nishiwaki T, Kaneko A, Masato H, Takahashi Y, Hayakawa A, Yazawa S, Kominato Y. Sano R, et al. Among authors: yazawa s. Sci Rep. 2023 Mar 27;13(1):4947. doi: 10.1038/s41598-023-31961-6. Sci Rep. 2023. PMID: 36973299 Free PMC article.

10

Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort.

Itamochi M, Yazawa S, Inasaki N, Saga Y, Yamazaki E, Shimada T, Tamura K, Maenishi E, Isobe J, Nakamura M, Takaoka M, Sasajima H, Kawashiri C, Tani H, Oishi K. Itamochi M, et al. Among authors: yazawa s. Vaccine. 2023 Mar 24;41(13):2234-2242. doi: 10.1016/j.vaccine.2023.02.068. Epub 2023 Feb 27. Vaccine. 2023. PMID: 36858871 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page